Thomas Delate

4.0k total citations · 1 hit paper
153 papers, 2.8k citations indexed

About

Thomas Delate is a scholar working on Cardiology and Cardiovascular Medicine, Geriatrics and Gerontology and Economics and Econometrics. According to data from OpenAlex, Thomas Delate has authored 153 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Cardiology and Cardiovascular Medicine, 35 papers in Geriatrics and Gerontology and 31 papers in Economics and Econometrics. Recurrent topics in Thomas Delate's work include Atrial Fibrillation Management and Outcomes (39 papers), Pharmaceutical Practices and Patient Outcomes (35 papers) and Venous Thromboembolism Diagnosis and Management (29 papers). Thomas Delate is often cited by papers focused on Atrial Fibrillation Management and Outcomes (39 papers), Pharmaceutical Practices and Patient Outcomes (35 papers) and Venous Thromboembolism Diagnosis and Management (29 papers). Thomas Delate collaborates with scholars based in United States, Canada and Italy. Thomas Delate's co-authors include Daniel M. Witt, Nathan P. Clark, Mark Crowther, Elaine M. Hylek, David García, Walter Ageno, Erin J. Aiello Bowles, Francesco Dentali, Karen McConnell and Stephen Joel Coons and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Thomas Delate

148 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Risk of Heart Failure in Breast Cancer Patients After Anthracycline and Trastuzumab Treatment: A Retrospective Cohort Study

2012 411 citations Erin J. Aiello Bowles, Robert Wellman et al. JNCI Journal of the National Cancer Institute profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Delate United States	28	1.2k	485	455	435	345	153	2.8k
Susanne M. Smorenburg Netherlands	26	1.3k 1.0×	686 1.4×	282 0.6×	464 1.1×	166 0.5×	46	4.4k
Joseph Menzin United States	35	602 0.5×	307 0.6×	415 0.9×	111 0.3×	584 1.7×	127	3.7k
Arlene M. Gallagher United Kingdom	19	851 0.7×	265 0.5×	454 1.0×	109 0.3×	306 0.9×	40	3.4k
Inmaculada Hernandez United States	26	864 0.7×	330 0.7×	109 0.2×	371 0.9×	632 1.8×	147	2.6k
Patrick Hosokawa United States	26	948 0.8×	230 0.5×	565 1.2×	235 0.5×	133 0.4×	81	3.0k
P. Ricordeau France	26	507 0.4×	145 0.3×	303 0.7×	198 0.5×	276 0.8×	69	2.4k
Kenneth M. Shermock United States	27	435 0.4×	504 1.0×	138 0.3×	258 0.6×	217 0.6×	89	2.0k
José Labarère France	33	701 0.6×	592 1.2×	145 0.3×	210 0.5×	178 0.5×	161	3.7k
Alice Chong Canada	29	1.7k 1.4×	110 0.2×	164 0.4×	308 0.7×	534 1.5×	74	3.1k
Winnie W. Nelson United States	29	1.3k 1.1×	640 1.3×	80 0.2×	190 0.4×	303 0.9×	113	2.8k

Countries citing papers authored by Thomas Delate

Since Specialization

Citations

This map shows the geographic impact of Thomas Delate's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Delate with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Delate more than expected).

Fields of papers citing papers by Thomas Delate

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Delate. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Delate. The network helps show where Thomas Delate may publish in the future.

Co-authorship network of co-authors of Thomas Delate

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Delate. A scholar is included among the top collaborators of Thomas Delate based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Delate. Thomas Delate is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Clark, Nathan P., et al.. (2025). Impact of cytochrome P-450 3A4 enzyme/P-glycoprotein inducing antiseizure medications on direct oral anticoagulant therapy. Blood Coagulation & Fibrinolysis. 36(3). 71–77. 1 indexed citations

Delate, Thomas, et al.. (2025). Methotrexate fixed dosing protocol for ambulatory treatment of ectopic pregnancy. Reproductive Sciences. 32(2). 428–434.

Niu, Fang, et al.. (2023). Real-World Clinical Outcomes of Bevacizumab-awwb Biosimilar versus Bevacizumab Reference Product in Patients with Metastatic Colorectal Cancer. BioDrugs. 37(6). 891–899. 3 indexed citations

Delate, Thomas, et al.. (2022). Impact of Palliative Care Clinical Pharmacists in an Inpatient Care Setting on Total Health Care Expenditures. Journal of Palliative Medicine. 25(10). 1518–1523. 3 indexed citations

Clark, Nathan P., et al.. (2022). Effectiveness and safety of direct oral anticoagulants in patients with venous thromboembolism and creatinine clearance < 30 mL/min. Journal of Thrombosis and Thrombolysis. 55(2). 355–364. 3 indexed citations

Tuzzio, Leah, Andrew Berry, Kathy Gleason, et al.. (2021). Aligning care with the personal values of patients with complex care needs. Health Services Research. 56(S1). 1037–1044. 10 indexed citations

Derington, Catherine G., Jordan B. King, Thomas Delate, et al.. (2020). Twice-daily versus once-daily lisinopril and losartan for hypertension: Real-world effectiveness and safety. PLoS ONE. 15(12). e0243371–e0243371. 1 indexed citations

Delate, Thomas, et al.. (2018). Effect of increased time in the therapeutic range on atrial fibrillation outcomes within a centralized anticoagulation service. Thrombosis Research. 163. 54–59. 13 indexed citations

Vogel, Erin A., et al.. (2016). Renal Drug Dosing. Applied Clinical Informatics. 7(3). 731–744. 6 indexed citations

10.

McConnell, Karen, et al.. (2015). The Sustainability of Improvements from Continuing Professional Development in Pharmacy Practice and Learning Behaviors. American Journal of Pharmaceutical Education. 79(3). 36–36. 10 indexed citations

11.

Delate, Thomas, et al.. (2015). Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism. Thrombosis Research. 137. 97–102. 8 indexed citations

12.

Delate, Thomas, et al.. (2014). Factors associated with first-line bevacizumab use in advanced non-squamous and non-small cell lung cancer. 2(1). 1–8. 5 indexed citations

13.

Bowles, Erin J. Aiello, Karen J. Wernli, Heidi J. Gray, et al.. (2014). Diffusion of Intraperitoneal Chemotherapy in Women with Advanced Ovarian Cancer in Community Settings 2003â€“2008: The Effect of the NCI Clinical Recommendation. Frontiers in Oncology. 4. 43–43. 15 indexed citations

14.

Johnson, Samuel G., et al.. (2013). Characterizing the financial burden of pulmonary arterial hypertension within an integrated healthcare delivery system. Journal of Medical Economics. 16(12). 1414–1422. 13 indexed citations

15.

Bowles, Erin J. Aiello, Robert Wellman, Heather Spencer Feigelson, et al.. (2012). Risk of Heart Failure in Breast Cancer Patients After Anthracycline and Trastuzumab Treatment: A Retrospective Cohort Study. JNCI Journal of the National Cancer Institute. 104(17). 1293–1305. 411 indexed citations breakdown →

16.

Witt, Daniel M., Thomas Delate, Mary Beth Dowd, et al.. (2009). Incidence and predictors of bleeding or thrombosis after polypectomy in patients receiving and not receiving anticoagulation therapy. Journal of Thrombosis and Haemostasis. 7(12). 1982–1989. 62 indexed citations

17.

Delate, Thomas, et al.. (2008). Clinical Outcomes of a Home‐Based Medication Reconciliation Program After Discharge from a Skilled Nursing Facility. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 28(4). 444–452. 59 indexed citations

18.

Johnson, Samuel G., et al.. (2008). Outcomes Associated With Combined Antiplatelet and Anticoagulant Therapy. CHEST Journal. 133(4). 948–954. 56 indexed citations

19.

Nelson, Kent, et al.. (2006). An evaluation of a clinical pharmacy-directed intervention on blood pressure control.. Dialnet (Universidad de la Rioja). 7 indexed citations

20.

Delate, Thomas, et al.. (2003). Commentary on using the SF-36 or MOS-HIV in studies of persons with HIV disease.. Health and Quality of Life Outcomes. 1(1). 25–25. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact